The Centricity of Decentricity: Breaking Down the Basics of Decentralized Clinical Trials
Patient recruitment, retention, diversity, safety, and data collection & analysis are all factors driving the need for radical innovation in clinical drug development. This need has been made painfully apparent during the current COVID-19 pandemic.
We can no longer ‘do the same thing and expect a different result’; it’s time to take giant steps forward. This White Paper outlines the methods Sponsors, Sites & CROs can adopt to digitally transform their protocols for improved scientific outcomes.
Medable strives to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies. The company’s digital platform streamlines design, recruitment, retention, and data quality for decentralized trials, replacing siloed systems with integrated digital tools to accelerate trial execution. Medable connects patients, sites, and sponsors to improve patient access, experience, and outcomes For more information, visit https://www.medable.com/.